SMTL ID : 9bo1.1

Crystal Structure of T190I SARS-CoV-2 Main Protease in Complex with Compound Mpro61

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.96 Å

Oligo State

homo-dimer

Ligands

1 x XEK: (5P)-5-[(1P,3M,3'P)-3-{3-chloro-5-[(2-chlorophenyl)methoxy]-4-fluorophenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl]-1-methylpyrimidine-2,4(1H,3H)-dione(Non-covalent)

XEK.1: 20 residues within 4Å: Chain A: T.25, T.26, H.41, F.140, L.141, N.142, G.143, S.144, C.145, H.163, H.164, M.165, E.166, L.167, P.168, D.187, R.188, Q.189, I.190, Q.192 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:M.165, A:P.168 Hydrogen bonds: A:T.26, A:T.26, A:G.143, A:E.166, A:Q.189 pi-Stacking: A:H.41

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kenneson, J.R. et al., Exploring Possible Drug-Resistant Variants of SARS-CoV-2 Main Protease (Mpro) with Noncovalent Preclinical Candidate, Mpro61. Acs Bio Med Chem Au (2025)

Release Date

2025-02-12

Peptides

3C-like proteinase nsp5: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

3C-like proteinase nsp5

Related Entries With Identical Sequence